Description of Patient Adherence to Heart Failure Remote Monitoring and Its Determinants
TELE'IC
1 other identifier
observational
150
1 country
2
Brief Summary
This is a monocentric cohort study, with retrospective data collection and prospective semi-structured interviews. All patients who, since 2020, have received telemonitoring for heart failure after hospitalization at the CHR Metz-Thionville will be included. Patients will be informed of the study by e-mail, or by post if no e-mail is available. Data concerning their socio-demographic and clinical characteristics will be collected from the computerized patient record, and telerecording data will be extracted from the telerecording software. Patients whose follow-up is still in progress will be monitored (=simple data collection) for 12 months, or until follow-up is terminated if necessary. Patients whose follow-up has been interrupted for less than a month at the start of the study (to avoid memory bias) or during the course of the study will be contacted by telephone by the IPA carrying out the telemonitoring, and offered, after oral consent, a semi-structured interview to investigate the reasons for the interruption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 4, 2024
CompletedFirst Posted
Study publicly available on registry
December 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedDecember 9, 2024
December 1, 2024
1 year
December 4, 2024
December 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to break in remote monitoring (survival)
Defined as the number of months of remote monitoring performed before interruption - no response from the patient after 6 weeks of reminders at a rate of 2 reminders per week, excluding justified absences. Cancellation of remote monitoring for any other reason will be considered a right censorship
up to four years after start of remote monitoring
Secondary Outcomes (4)
Proportion of patients who break off follow-up at 6 months
6 months after start of remote monitoring
Proportion of patients who break off follow-up at 12 months
12 months after start of remote monitoring
Proportion of patients who break off follow-up at 24 months
24 months after start of remote monitoring
Break-off
up to four years after start of remote monitoring
Eligibility Criteria
Heart failure patients
You may qualify if:
- Major patient
- Heart failure
- Having received telemonitoring for heart failure from the CHR
- Patient clearly informed about the research in progress
- Gave oral consent for telephone interview
You may not qualify if:
- Refusal to reuse data for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHR Metz Thionville Hopital de Mercy
Metz, 57085, France
CHR Metz-Thionville Hopital Bel Air
Thionville, 57100, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2024
First Posted
December 9, 2024
Study Start
July 1, 2024
Primary Completion
July 1, 2025
Study Completion
July 1, 2025
Last Updated
December 9, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share